Response to CMA provisional decision announcement
CMA publishes provisional decision in veterinary market investigation with 21 proposed remedies; CVS to respond and implement measures.
Select text to share a quote on X · sign in to keep highlights & notes in your CVSG notes
CVS notes this morning's publication by the Competition and Markets Authority ("CMA") of the summary of its provisional decision in the veterinary market investigation. The CMA is expected to publish its full provisional decision later today.
CVS welcomes the additional certainty that this morning's announcement brings. We will be responding to the provisional decision and proposed remedies package in writing in due course and have a further hearing with the CMA in December 2025. We look forward to the publication of the final decision in March 2026 and conclusion of this market investigation promptly thereafter.
We are pleased to see that the CMA has considered our and the veterinary profession's feedback on the initial 28 remedies proposed in May 2025, which have been refined to 21 with no new remedies introduced. Whilst we do not believe that all of these remedies are fully justified, we will be working with the CMA to refine the remedies package to ensure it is workable and deliverable and have plans in place to implement them, including joint branding of our practices and the publishing of standardised price lists.
As such, the Board continues to expect the Group to trade in line with market expectations.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.